Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02641288Phase 3Completed
Phase 3, randomised trial in postoperative pain comparing Ropivacaine with Placebo (2 arms). Primary endpoint: Pain at 24 hours. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02641288.